U.S. markets open in 8 hours 43 minutes

Globus Medical, Inc. (GMED)

NYSE - NYSE Delayed Price. Currency in USD
44.89-1.18 (-2.56%)
At close: 04:00PM EST
45.28 +0.39 (+0.87%)
After hours: 05:30PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Triple Moving Average Crossover

Triple Moving Average Crossover

Previous Close46.07
Bid0.00 x 1000
Ask0.00 x 1200
Day's Range44.88 - 46.10
52 Week Range43.39 - 80.04
Avg. Volume1,961,440
Market Cap6.186B
Beta (5Y Monthly)1.10
PE Ratio (TTM)30.54
EPS (TTM)1.47
Earnings DateFeb 19, 2024 - Feb 23, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est63.58
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Near Fair Value
-2% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for GMED

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Globus Medical, Inc.
    GMED: What does Argus have to say about GMED?GLOBUS MEDICAL INC - A has an Investment Rating of SELL; a target price of $37.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
    Fair Value
    Economic Moat
    7 days agoArgus Research
View more
  • Insider Monkey

    Globus Medical, Inc. (NYSE:GMED) Q3 2023 Earnings Call Transcript

    Globus Medical, Inc. (NYSE:GMED) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Thank you for standing by, and welcome to the Globus Medical Third Quarter 2023 Earnings Call. [Operator Instructions]. I will now turn the call over to Brian Kearns, Senior Vice President of Business Development and Investor Relations. Mr. Kearns, please go ahead. […]

  • Zacks

    Globus Medical (GMED) Q3 Earnings Top Estimates, Margins Down

    Globus Medical's (GMED) legacy business continues to drive share growth across its U.S. spine and trauma portfolios in the third quarter.

  • Motley Fool

    Globus Medical (GMED) Q3 2023 Earnings Call Transcript

    Thank you for standing by, and welcome to the Globus Medical third-quarter 2023 earnings call. Joining today's call for Globus Medical will be Dan Scavilla, president and CEO; and Keith Pfeil, chief financial officer. This review is being made available via webcast accessible through Investor Relations section of the Globus Medical website at